Skip to content

Publication Date: October 2025

From fast follower to fast leader: My journey into China’s biotech boom

China’s biotech push is reshaping global pharma and challenging US scientific leadership. After a research trip to Shanghai, Franklin Equity Group’s Evan McCulloch highlights the implications for US and European biotech firms.
Client Use: 
Yes
Literature Code: 
FEG25-CHBIO
Format 
PDF